Evaluation of the Use of the RELAX® Glasses on the Anxiety of Patients Undergoing Emergency Hand Surgery Under Locoregional Anesthesia
RELAX
1 other identifier
interventional
171
1 country
1
Brief Summary
More than 90% of hand surgery is performed under local anesthesia and can be a source of anxiety, especially in an emergency context. The management of this intraoperative anxiety is essential for the comfort. The use of a virtual reality headset has shown its effectiveness in reducing anxiety in dental surgery or hand surgery under local anesthesia with the WALANT technique. On the other hand, virtual reality and the use of 3D can cause discomfort and side effects such as nausea and dizziness. It is known that audiovisual distraction also effectively reduces pain and anxiety in patients with fewer side effects. The investigators have therefore chosen to use the RELAX® glasses. There are no publications examining the effectiveness of positive distraction as a non-pharmacological agent to improve the patient experience during emergency management in the operating room in the context of hand surgery under locoregional anesthesia. The investigatos would like to study its action on the anxiety, pain and global satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable surgery
Started May 2022
Shorter than P25 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2022
CompletedFirst Submitted
Initial submission to the registry
August 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
May 30, 2024
CompletedMay 30, 2024
May 1, 2024
4 months
August 29, 2022
May 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in visual analogue scale anxiety scores after emergency hand surgery
The visual analogue anxiety scale from 0 to 10, with 0 meaning no anxiety and 10 very high anxiety.
In the 5 minutes after the end of emergency hand surgery
Secondary Outcomes (5)
Overall satisfaction between the group using RELAX glasses and the group following the usual course (without RELAX glasses) measured by a visual analogue scale
Immediate postoperative
Variation in pain between entering and leaving the operating theatre between the 2 arms using a visual analogue scale
In the 5 minutes after the end of emergency hand surgery
Rate of patients receiving at least one additional analgesic
Immediate after locoregional anaesthesia
Rate of patients receiving at least one additional anxiolytic
Immediate after locoregional anaesthesia
Pre-existing anxiety, only in patients receiving RELAX glasses, measured with the STAI-YB score
7-days after emergency hand surgery
Study Arms (2)
Group with RELAX® glasses
EXPERIMENTALGroup without RELAX® glasses
NO INTERVENTIONInterventions
Glasses which are a solution of audiovisual sedation by positive distraction for hospital medical use.
Eligibility Criteria
You may qualify if:
- Patients treated for hand surgery under emergency locoregional anesthesia (Wounds, fractures and infections of the hand and wrist).
- Patient with written consent or additional parental consent in the case of minor patients.
- Socially insured patient.
- Patient willing to comply with all study procedures and duration.
You may not qualify if:
- Medical history contraindicating RELAX glasses: claustrophobia.
- Known and current alcohol and/or illicit drug abuse that may interfere with patient safety and/or compliance.
- Any condition that would make the patient unfit for the study: current presence of cognitive impairment (MMS \<15), severe psychiatric disorders (bipolar disorder, psychotic disorders according to the DSM-V classification).
- Pregnant or breastfeeding woman.
- Patient under court protection.
- Patient participating in another study.
- Patient's refusal to use the headset.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de Valenciennes
Valenciennes, 59300, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2022
First Posted
May 30, 2024
Study Start
May 2, 2022
Primary Completion
August 30, 2022
Study Completion
September 6, 2022
Last Updated
May 30, 2024
Record last verified: 2024-05